RIGGS RORY B Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$420,000.00
Insider Sells Quantity
35
Insider Sells Sum
$225.33M

Insider Activity of RIGGS RORY B

Biography of RIGGS RORY B

No biography is available at this moment.

2024-01-04SaleRoyalty Pharma plc
RPRX
director
35,702
0.0083%
$27.55$983,504+1.69%
2024-01-03SaleRoyalty Pharma plc
RPRX
director
199,098
0.0467%
$27.79$5.53M+1.83%
2024-01-02SaleRoyalty Pharma plc
RPRX
director
235,200
0.0566%
$28.52$6.71M-0.09%
2023-05-22SaleRoyalty Pharma plc
RPRX
director
1.75M
0.4849%
$32.82$57.44M-12.04%
2023-03-30SaleRoyalty Pharma plc
RPRX
director
130,024
0.0398%
$36.26$4.71M-16.75%
2023-03-29SaleRoyalty Pharma plc
RPRX
director
9,926
0.0031%
$36.95$366,766-17.28%
2022-12-09SaleRoyalty Pharma plc
RPRX
director
19,990
0.0071%
$42.07$840,939-21.92%
2022-11-17SaleRoyalty Pharma plc
RPRX
director
120,000
0.0429%
$42.33$5.08M-20.43%
2022-09-15SaleRoyalty Pharma plc
RPRX
director
52,025
0.0185%
$42.21$2.2M-13.58%
2022-09-14SaleRoyalty Pharma plc
RPRX
director
47,975
0.0172%
$42.41$2.03M-14.09%
2022-08-09SaleRoyalty Pharma plc
RPRX
45,000
0.0166%
$43.73$1.97M-12.03%
2022-06-29SaleRoyalty Pharma plc
RPRX
30,000
0.0107%
$42.17$1.27M-5.58%
2022-05-19SaleRoyalty Pharma plc
RPRX
150,000
0.0499%
$39.42$5.91M+1.84%
2022-03-29SaleRoyalty Pharma plc
RPRX
60,000
0.0195%
$38.59$2.32M+7.04%
2022-03-18SaleRoyalty Pharma plc
RPRX
director
129,222
0.0431%
$39.55$5.11M+5.47%
2022-03-17SaleRoyalty Pharma plc
RPRX
14,322
0.0047%
$39.05$559,288+4.26%
2021-12-29SaleRoyalty Pharma plc
RPRX
director
75,000
0.0253%
$40.00$3M+4.28%
2021-12-28SaleRoyalty Pharma plc
RPRX
director
109,448
0.0371%
$40.21$4.4M+3.3%
2021-11-17SaleRoyalty Pharma plc
RPRX
director
201,824
0.0722%
$42.36$8.55M-2.04%
2021-11-16SaleRoyalty Pharma plc
RPRX
director
12,565
0.0045%
$42.01$527,805-0.88%
Total: 29
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.